Tel-Hashomer, Israel--(ENEWSPF)--April 21, 2016. The administration of the cannabinoids THC and CBD limit cancer activity in neuroblastoma cells in culture and in animals, according to preclinical data published in the journal Current Oncology. Neuroblastoma is an aggressive form of childhood cancer that often goes inadequately addressed by conventional treatment.
Investigators reported that both types of cannabinoids reduced neuroblastoma cell viability, but that CBD demonstrated superior . . .